Compare AORT & AI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AORT | AI |
|---|---|---|
| Founded | 1984 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | 1993 | 2020 |
| Metric | AORT | AI |
|---|---|---|
| Price | $46.50 | $13.97 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 14 |
| Target Price | ★ $49.36 | $20.00 |
| AVG Volume (30 Days) | 358.0K | ★ 5.5M |
| Earning Date | 11-06-2025 | 12-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $422,646,000.00 | $352,913,000.00 |
| Revenue This Year | $15.97 | N/A |
| Revenue Next Year | $10.96 | $11.19 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 9.81 | 1.84 |
| 52 Week Low | $21.97 | $12.59 |
| 52 Week High | $48.25 | $38.58 |
| Indicator | AORT | AI |
|---|---|---|
| Relative Strength Index (RSI) | 53.55 | 41.48 |
| Support Level | $45.41 | $13.70 |
| Resistance Level | $48.00 | $15.03 |
| Average True Range (ATR) | 1.43 | 0.65 |
| MACD | 0.09 | -0.05 |
| Stochastic Oscillator | 64.81 | 9.07 |
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications: C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications: and C3 Generative AI, which combines the utility of large language models. Geographically the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.